QUINOXALINES AND AZA-QUINOXALINES AS CRTH2 RECEPTOR MODULATORS
申请人:Boyce Christopher W.
公开号:US20130303517A1
公开(公告)日:2013-11-14
The invention provides certain quinoxalines and aza-quinoxalines of the Formula (I), and their pharmaceutically acceptable salts, wherein J
1
, J
2
, R
1
, R
2
, R
3
, R
22
, R
a
, R
b
, R
c
, R
d
, X, Y, b, n, and q are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with uncontrolled or inappropriate stimulation of CRTH
2
function.